Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® -January 04, 2024 at 12:01 pm EST
Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE® Crossject expanding market access activities in preparation for filing for marketing...
Source: marketscreener.com